ArticleNPJ digital medicine2026
Knowledge-graph embeddings for osteoarthritis candidate prediction.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoarthritis (OA) is a prevalent, disabling joint disease with no approved disease modifying treatments. We present a knowledge-graph based approach to discover candidate treatments for OA by integrating large-scale biomedical data. We introduce the Osteoarthritis Knowledge-graph (OKG), a comprehensive network derived from the Drug Repurposing Knowledge-graph (DRKG) and enriched with causal genetic associations from OA genome-wide association study (GWAS) involving nearly 2 million individuals. We propose CausalPathKG, a knowledge-graph embedding model built upon RotatE that integrates domain specific innovations: (i) weighted gene OA edges reflecting GWAS significance, (ii) a path based regularization term to encourage drug gene OA causal connectivity, (iii) multi hop graph attention to prioritize informative paths, and (iv) self adversarial negative sampling with type consistent corruptions for robust training. CausalPathKG was trained to predict missing links, while withholding known OA-related edges for testing. In experiments, CausalPathKG outperformed TransE and RotatE baselines in predicting held out OA treatments, achieving higher link prediction accuracy and classification performance. Case studies highlight that top ranked repurposed drugs engage key OA-associated genes and pathways identified in human genetics. These results demonstrate that incorporating genetic evidence into knowledge-graph models can improve the discovery of therapeutics, offering a computational strategy to bridge human genomic data with drug repurposing.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.